172 related articles for article (PubMed ID: 28161543)
1. Anal study in immunocompetent women with human papillomavirus related lower genital tract pathology.
Donaire C; Reillo M; Martínez-Escoriza JC; López-Fernández JA
Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():15-20. PubMed ID: 28161543
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Anal Cytology in Women with History of Abnormal Pap Smear, Cervical Intraepithelial Neoplasia, Cervical Cancer and High Risk HPV for Anogenital Dysplasia.
Hosseini MS; Khosravi D; Farzaneh F; Ebrahimi A; Arab M; Ashraf Ganjoie T; Jamdar F; Moridi A; Chehrazi M
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3071-3075. PubMed ID: 30485943
[TBL] [Abstract][Full Text] [Related]
3. Anal and Cervical High-Risk Human Papillomavirus Genotyping in Women With and Without Genital Neoplasia.
Bregar AJ; Cronin B; Luis C; DiSilvestro P; Schechter S; Pisharodi L; Raker C; Clark M; Robison K
J Low Genit Tract Dis; 2018 Apr; 22(2):115-119. PubMed ID: 29481422
[TBL] [Abstract][Full Text] [Related]
4. The relationship between the cervical and anal HPV infection in women with cervical intraepithelial neoplasia.
Sehnal B; Dusek L; Cibula D; Zima T; Halaska M; Driak D; Slama J
J Clin Virol; 2014 Jan; 59(1):18-23. PubMed ID: 24315797
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the prevalence of human papillomavirus and abnormal anal cytology in women at risk.
Lopez-Cavanillas B; G Benitez C; Serrano M; Sendagorta E; Hernandez A; Bartha JL
J Obstet Gynaecol; 2021 Oct; 41(7):1139-1144. PubMed ID: 33459109
[TBL] [Abstract][Full Text] [Related]
6. Concurrent anal human papillomavirus and abnormal anal cytology in women with known cervical dysplasia.
Lammé J; Pattaratornkosohn T; Mercado-Abadie J; Alkhas A; Robinson A; Lanneau G
Obstet Gynecol; 2014 Aug; 124(2 Pt 1):242-248. PubMed ID: 25004339
[TBL] [Abstract][Full Text] [Related]
7. Anal Cytology and Human Papillomavirus Genotyping in Women With a History of Lower Genital Tract Neoplasia Compared With Low-Risk Women.
Robison K; Cronin B; Bregar A; Luis C; DiSilvestro P; Schechter S; Pisharodi L; Raker C; Clark M
Obstet Gynecol; 2015 Dec; 126(6):1294-1300. PubMed ID: 26551180
[TBL] [Abstract][Full Text] [Related]
8. Anal human papillomavirus infection and abnormal anal cytology in women with genital neoplasia.
Park IU; Ogilvie JW; Anderson KE; Li ZZ; Darrah L; Madoff R; Downs L
Gynecol Oncol; 2009 Sep; 114(3):399-403. PubMed ID: 19501896
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of anal cytology and dysplasia in women with a history of lower genital tract dysplasia and malignancy.
Cronin B; Bregar A; Luis C; Schechter S; Disilvestro P; Pisharodi L; Sung CJ; Raker C; Clark M; Robison K
Gynecol Oncol; 2016 Jun; 141(3):492-496. PubMed ID: 27095188
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of anal dysplasia and HPV genotypes in gynecology patients: The ANGY cross-sectional prospective clinical study protocol.
Pache B; Balaya V; Mathis J; Hübner M; Sahli R; Cavassini M; Sempoux C; Mathevet P; Jacot-Guillarmod M
PLoS One; 2022; 17(10):e0276438. PubMed ID: 36269726
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Specific Types of Human Papiloma Virus in Cervical Intraepithelial Lesions and Cervical Cancer in Macedonian Women.
Aleksioska-Papestiev I; Chibisheva V; Micevska M; Dimitrov G
Med Arch; 2018 Feb; 72(1):26-30. PubMed ID: 29416214
[TBL] [Abstract][Full Text] [Related]
12. Cytology-based screening for anal intraepithelial neoplasia in women with a history of cervical intraepithelial neoplasia or cancer.
Wohlmuth C; Ghorab Z; Shier M; Tinmouth J; Salit IE; Covens A; Zhang L; Vicus D
Cancer Cytopathol; 2021 Feb; 129(2):140-147. PubMed ID: 33002327
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of high-grade anal dysplasia among women with high-grade lower genital tract dysplasia or cancer: Results of a pilot study.
Fokom Domgue J; Messick C; Milbourne A; Guo M; Salcedo MP; Dahlstrom KR; Chiao EY; Deshmukh AA; Sturgis EM; Schmeler KM
Gynecol Oncol; 2019 May; 153(2):266-270. PubMed ID: 30827725
[TBL] [Abstract][Full Text] [Related]
14. Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women.
Hessol NA; Holly EA; Efird JT; Minkoff H; Schowalter K; Darragh TM; Burk RD; Strickler HD; Greenblatt RM; Palefsky JM
AIDS; 2009 Jan; 23(1):59-70. PubMed ID: 19050387
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of high-grade anal intraepithelial neoplasia in immunocompetent women treated for high-grade cervical intraepithelial neoplasia.
Monti E; Salmaso M; Alberico D; Emily Cetera G; Viscardi A; Boero V; Di Loreto E; Libutti G; Roncella E; Barbara G
Eur J Obstet Gynecol Reprod Biol; 2023 Dec; 291():82-87. PubMed ID: 37852112
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus DNA and mRNA positivity of the anal canal in women with lower genital tract HPV lesions: predictors and clinical implications.
Valari O; Koliopoulos G; Karakitsos P; Valasoulis G; Founta C; Godevenos D; Dova L; Paschopoulos M; Loufopoulos A; Paraskevaidis E
Gynecol Oncol; 2011 Sep; 122(3):505-8. PubMed ID: 21665253
[TBL] [Abstract][Full Text] [Related]
17. Cross-sectional study of anal intraepithelial lesions in women with cervical neoplasia without HIV.
Heráclio SA; de Souza ASR; de Souza PRE; Katz L; Lima Junior SF; Amorim MMR
Int J Gynaecol Obstet; 2018 Feb; 140(2):233-240. PubMed ID: 29080327
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for abnormal anal cytology in young heterosexual women.
Moscicki AB; Hills NK; Shiboski S; Darragh TM; Jay N; Powell K; Hanson E; Miller SB; Farhat S; Palefsky J
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):173-8. PubMed ID: 10067816
[TBL] [Abstract][Full Text] [Related]
19. Study on the prevalence of human papillomavirus in the anal canal of women with cervical intraepithelial neoplasia grade III.
Véo CA; Saad SS; Nicolau SM; Melani AG; Denadai MV
Eur J Obstet Gynecol Reprod Biol; 2008 Sep; 140(1):103-7. PubMed ID: 18472205
[TBL] [Abstract][Full Text] [Related]
20. A Cross-Sectional Study of the Prevalence of Anal Dysplasia among Women with High-Grade Cervical, Vaginal, and Vulvar Dysplasia or Cancer: The PANDA Study.
Batman S; Messick CA; Milbourne A; Guo M; Munsell MF; Fokom-Domgue J; Salcedo M; Deshmukh A; Dahlstrom KR; Ogburn M; Price A; Fleming ND; Taylor J; Shafer A; Cobb L; Sigel K; Sturgis EM; Chiao EY; Schmeler KM
Cancer Epidemiol Biomarkers Prev; 2022 Dec; 31(12):2185-2191. PubMed ID: 36126275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
